医学
内科学
脂肪肝
胃肠病学
利拉鲁肽
肝硬化
脂肪变性
肝病
非酒精性脂肪肝
胰岛素抵抗
肥胖
代理终结点
丙氨酸转氨酶
内分泌学
糖尿病
疾病
2型糖尿病
作者
Jungha Park,Jin Wook Kim,Soo Mee Lim
摘要
Liraglutide 3.0 mg improved surrogate markers of MASLD in individuals with obesity, suggesting it may be a promising approach to address both conditions concurrently.
科研通智能强力驱动
Strongly Powered by AbleSci AI